In the early stages, resources are limited and spending them correctly can raise your chances of having a smooth experience.

AstraZeneca is leaving no stone unturned in its effort to make baxdrostat the first aldosterone synthase inhibitor (ASI) to get approval for hard-to-treat hypertension. The FDA has now started a ...

Headlines have been flush with stories reporting the death of ESG. But in reality, it’s been more of a ‘reset’ than a ‘retreat.’ We dig into the challenges and opportunities businesses will face in ...

AI agents are now being weaponized through prompt injection, exposing why model guardrails are not enough to protect enterprise data. If you can only read one tech story a day, this is it. We use ...